Schizophrenia remains a challenging disease to treat effectively with current antipsychotic medications due to their limited efficacy across the entire spectrum of core symptoms as well …
MA Lynch - Physiological reviews, 2004 - journals.physiology.org
Abstract Lynch, MA. Long-Term Potentiation and Memory. Physiol Rev 84: 87–136, 2004; 10.1152/physrev. 00014.2003.—One of the most significant challenges in neuroscience is to …
G-protein-coupled receptors (GPCRs) play critical roles in regulating brain function. Recent advances have greatly expanded our understanding of these receptors as complex …
Although schizophrenia is an illness that has been historically characterized by the presence of positive symptomatology, decades of research highlight the importance of …
Dr. Jacqueline N. Crawley, author of the First and Second Editions of What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, continues to field calls …
N Watamura, N Kakiya, R Fujioka, N Kamano… - Science …, 2024 - science.org
Deposition of amyloid-β (Aβ) in the brain can impair neuronal function and contribute to cognitive decline in Alzheimer's disease (AD). Here, we found that dopamine and the …
NH Greig, T Utsuki, DK Ingram… - Proceedings of the …, 2005 - National Acad Sciences
Like acetylcholinesterase, butyrylcholinesterase (BChE) inactivates the neurotransmitter acetylcholine (ACh) and is hence a viable therapeutic target in Alzheimer's disease, which is …
Research during the last decade has significantly advanced our understanding of the molecular mechanisms at the interface between the nervous system and the immune …
Cholinergic neurons are widespread, and pharmacological modulation of acetylcholine receptors affects numerous brain processes, but such modulation entails side effects due to …